Latest Comments

BMS shifts towards precision medicine

BMS shifts towards precision medicine

pSivida and Alimera enter new phase of collaboration on the longest-acting ocular steroid implant

pSivida and Alimera enter new phase of collaboration on the longest-acting ocular steroid implant

Dynavax’s Heplisav-B passes key regulatory hurdle with FDA Advisory Committee endorsement

Dynavax’s Heplisav-B passes key regulatory hurdle with FDA Advisory Committee endorsement

Fighting obesity: Past and future treatments

Fighting obesity: Past and future treatments

A vaccine for Lyme disease – second time lucky?

A vaccine for Lyme disease – second time lucky?

Breakthroughs for orphan designated hematological drugs could earn big revenues

Breakthroughs for orphan designated hematological drugs could earn big revenues

Strong safety and efficacy data position Aerie Pharmaceuticals to submit glaucoma NDA for Roclatan

Strong safety and efficacy data position Aerie Pharmaceuticals to submit glaucoma NDA for Roclatan

NICE: too nice for too long?

NICE: too nice for too long?

Will lampalizumab finally provide a treatment for macular degeneration?

Will lampalizumab finally provide a treatment for macular degeneration?

Gilead looks to maintain dominance in HIV with its novel STR

Gilead looks to maintain dominance in HIV with its novel STR

Arena Pharmaceuticals’ positive topline Phase II results for ralinepag pose threat for J&J’s Uptravi

Arena Pharmaceuticals’ positive topline Phase II results for ralinepag pose threat for J&J’s Uptravi

Hemophilia gene therapies impress, but pricing doubts remain

Hemophilia gene therapies impress, but pricing doubts remain

Nestling in: food giant makes its mark on the healthcare industry

Nestling in: food giant makes its mark on the healthcare industry

Merck’s Keytruda stumbles in multiple myeloma

Merck’s Keytruda stumbles in multiple myeloma

FDA’s New Price-Tackling Strategy Puts Pressure on the Pharmaceutical Industry

FDA’s New Price-Tackling Strategy Puts Pressure on the Pharmaceutical Industry

Samsung Bioepis emerging as strong player in the Autoimmune space

Samsung Bioepis emerging as strong player in the Autoimmune space

EHA 2017: Targeting the Metabolic Control of the Epigenetic Machinery in R/R AML

EHA 2017: Targeting the Metabolic Control of the Epigenetic Machinery in R/R AML

EHA 2017: Novartis is Leading the CAR-T Cell Race

EHA 2017: Novartis is Leading the CAR-T Cell Race

EHA 2017: New Hope for Multiple Myeloma Patients

EHA 2017: New Hope for Multiple Myeloma Patients

EHA 2017: BCl-2 as an Emerging Target for AML

EHA 2017: BCl-2 as an Emerging Target for AML

EULAR 2017: Considerations after first TNF-failure in RA

EULAR 2017: Considerations after first TNF-failure in RA